Medical device commercialization

The FDA lets one phlebotomist supervise three autonomous blood-draw robots at once

Vitestro's Aletta is the first standalone blood-draw robot authorized in the United States. What builders will actually price is the supervision ratio the FDA attached to it and the 6% of patients the machine handed back to a human.